XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,336,544 | -20.4% | 68,400 | -10.3% | 0.00% | – |
| Q2 2023 | $2,934,894 | +172.7% | 76,231 | +153.5% | 0.00% | – |
| Q1 2023 | $1,076,170 | +53.3% | 30,069 | +68.9% | 0.00% | – |
| Q4 2022 | $701,854 | -67.1% | 17,800 | -69.9% | 0.00% | – |
| Q3 2022 | $2,134,000 | -24.5% | 59,100 | -36.4% | 0.00% | – |
| Q2 2022 | $2,828,000 | -6.5% | 92,989 | -6.0% | 0.00% | – |
| Q1 2022 | $3,023,000 | -67.0% | 98,891 | -66.2% | 0.00% | – |
| Q4 2021 | $9,154,000 | +70.6% | 293,000 | -16.5% | 0.00% | – |
| Q3 2021 | $5,365,000 | +454.2% | 351,079 | +575.4% | 0.00% | – |
| Q2 2021 | $968,000 | +108.2% | 51,981 | +100.1% | 0.00% | – |
| Q1 2021 | $465,000 | +662.3% | 25,982 | +34.8% | 0.00% | – |
| Q2 2017 | $61,000 | – | 19,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |